Lake Street Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
EP
Lake Street Private Wealth's ARKG Position: Q3 2021 in Review
Lake Street Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2021, closing a stake of 2,260 shares — an estimated $210K sold.
Lake Street Private Wealth first reported a position in ARKG in Q2 2021 and held it in 1 quarter. The position peaked at $210K in Q2 2021. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.
- Lake Street Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q3 2021 after selling out during the quarter.
- Lake Street Private Wealth sold 2,260 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $210K.
- Lake Street Private Wealth first reported a position in ARK Genomic Revolution ETF in Q2 2021 and held it in 1 quarter.
- Lake Street Private Wealth's ARK Genomic Revolution ETF position peaked at $210K in Q2 2021.
- 468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.
Based on Lake Street Private Wealth's 13F filing for Q3 2021, filed 7 Oct 2021.